| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | PKAca, Active |
|---|
| Description | Most of the effects of cAMP are mediated through the phosphorylation of target proteins on serine or threonine residues by the cAMP-dependent protein kinase (AMPK). The inactive holoenzyme of AMPK is a tetramer composed of two regulatory and two catalytic subunits. The mammalian catalytic subunit has been shown to consist of three PKA gene products: C-α, C-β, and C-γ. Two PKA isoforms exist, designated types I and II, which differ in their dimeric regulatory subunits, designated RI and RII, respectively. Furthermore, there are at least four different regulatory subunits: RI-α, RI-β, RII-α, and RII-β. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to fo |
|---|
| Size | 5 μg |
|---|
| Concentration | 5μg/50 μl |
|---|
| Applications | RUO |
|---|
| Other Names | PKA, cAMP-dependent protein kinase catalytic subunit alpha |
|---|
| Gene, Accession, CAS # | PRKACA, Gene ID: 5566, Accession: NM_002730. |
|---|
| Catalog # | 7743-5 |
|---|
| Price | |
|---|
| Order / More Info | PKAca, Active from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|